Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan

Antiviral Research

Volumn 88, Issue 3, 2010, Pages 256-262

  Yang, Ji Rong ^a   Huang, Yuan Pin ^a   Lin, Yu Cheng ^a   Su, Chun Hui ^a   Kuo, Chuan Yi ^a   Hsu, Li Ching ^a   Wu, Ho Sheng ^a,b   Liu, Ming Tsan ^a  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Influenza A virus; Neuraminidase; Oseltamivir resistant; Pandemic H1N1 2009

Indexed keywords

OSELTAMIVIR; SIALIDASE; VIRUS HEMAGGLUTININ;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; CELL STRAIN; CHILD; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GENE SEQUENCE; HUMAN; IN VIVO STUDY; INFANT; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MALE; NONHUMAN; PANDEMIC INFLUENZA; PHYLOGENY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TAIWAN;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CHILD; CHILD, PRESCHOOL; DOGS; DRUG RESISTANCE, VIRAL; FEMALE; GENES, VIRAL; HEMAGGLUTININS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEURAMINIDASE; OSELTAMIVIR; PANDEMICS; PHYLOGENY; TAIWAN; TIME FACTORS; YOUNG ADULT;

INFLUENZA A VIRUS;

EID: 78650230664     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.09.014     Document Type: Article

References (29)

1. Bai G.R., Chittaganpitch M., Kanai Y., Li Y.G., Auwanit W., Ikuta K., Sawanpanyalert P. Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand. Biochem. Biophys. Res. Commun. 2009, 390:897-901.
2. Baz M., Abed Y., Papenburg J., Bouhy X., Hamelin M.E., Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N. Engl. J. Med. 2009, 361:2296-2297.
3. Bloom J.D., Gong L.I., Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 2010, 328:1272-1275.
4. CDC Outbreak of swine-origin influenza A (H1N1) virus infection-Mexico, March-April 2009. MMWR Morb. Mortal. Wkly. Rep. 2009, 58:467-470.
5. CDC Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb. Mortal. Wkly. Rep. 2009, 58:433-435.
6. Chen H., Cheung C.L., Tai H., Zhao P., Chan J.F., Cheng V.C., Chan K.H., Yuen K.Y. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg. Infect. Dis. 2009, 15:1970-1972.
7. de Jong M.D., Tran T.T., Truong H.K., Vo M.H., Smith G.J., Nguyen V.C., Bach V.C., Phan T.Q., Do Q.H., Guan Y., Peiris J.S., Tran T.H., Farrar J. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 2005, 353:2667-2672.
8. Gubareva L.V., Webster R.G., Hayden F.G. Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res. 2002, 53:47-61.
9. Hauge S.H., Dudman S., Borgen K., Lackenby A., Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-2008. Emerg. Infect. Dis. 2009, 15:155-162.
10. Hurt A.C., Ernest J., Deng Y.M., Iannello P., Besselaar T.G., Birch C., Buchy P., Chittaganpitch M., Chiu S.C., Dwyer D., Guigon A., Harrower B., Kei I.P., Kok T., Lin C., McPhie K., Mohd A., Olveda R., Panayotou T., Rawlinson W., Scott L., Smith D., D'Souza H., Komadina N., Shaw R., Kelso A., Barr I.G. Emergence and spread of oseltamivir-resistant A (H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res. 2009, 83:90-93.
11. Hurt A.C., Holien J.K., Parker M., Kelso A., Barr I.G. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J. Virol. 2009, 83:10366-10373.
12. Hurt A.C., Selleck P., Komadina N., Shaw R., Brown L., Barr I.G. Susceptibility of highly pathogenic A (H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Res. 2007, 73:228-231.
13. Lackenby A., Democratis J., Siqueira M.M., Zambon M.C. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir. Ther. 2008, 13:809-820.
14. Lackenby A., Hungnes O., Dudman S.G., Meijer A., Paget W.J., Hay A.J., Zambon M.C. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Eur. Surveill. 2008, 13:pii 8026.
15. Le Q.M., Kiso M., Someya K., Sakai Y.T., Nguyen T.H., Nguyen K.H., Pham N.D., Ngyen H.H., Yamada S., Muramoto Y., Horimoto T., Takada A., Goto H., Suzuki T., Suzuki Y., Kawaoka Y. Avian flu: isolation of drug-resistant H5N1 virus. Nature 2005, 437:1108.
16. Mai L.Q., Wertheim H.F., Duong T.N., van Doorn H.R., Tran Hien N., Horby P. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N. Engl. J. Med. 2009, 362:86-87.
17. Meijer A., Lackenby A., Hungnes O., Lina B., van-der-Werf S., Schweiger B., Opp M., Paget J., van-de-Kassteele J., Hay A., Zambon M. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-2008 season. Emerg. Infect. Dis. 2009, 15:552-560.
18. Nelson M., Spiro D., Wentworth D., Beck E., Fan J., Ghedin E., Halpin R., Bera J., Hine E., Proudfoot K., Stockwell T., Lin X., Griesemer S., Kumar S., Bose M., Viboud C., Holmes E., Henrickson K. The early diversification of influenza A/H1N1pdm. PLoS Curr. Influenza 2009, RRN1126.
19. Okomo-Adhiambo M., Nguyen H.T., Sleeman K., Sheu T.G., Deyde V.M., Garten R.J., Xu X., Shaw M.W., Klimov A.I., Gubareva L.V. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A (H1N1) viruses. Antiviral Res. 2010, 85:381-388.
20. Sheu T.G., Deyde V.M., Okomo-Adhiambo M., Garten R.J., Xu X., Bright R.A., Butler E.N., Wallis T.R., Klimov A.I., Gubareva L.V. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 2008, 52:3284-3292.
21. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24:1596-1599.
22. Ward P., Small I., Smith J., Suter P., Dutkowski R. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J. Antimicrob. Chemother. 2005, 55(Suppl. 1):i5-i21.
23. Whitley R.J., Hayden F.G., Reisinger K.S., Young N., Dutkowski R., Ipe D., Mills R.G., Ward P. Oral oseltamivir treatment of influenza in children. Pediatr. Infect. Dis. J. 2001, 20:127-133.
24. WHO Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons. Wkly. Epidemiol. Rec. 2007, 82:149-150.
25. WHO, 2009a. Influenza (seasonal). Fact sheet no. N 211. Available from Accessed 23 October 2009. http://www.who.int/mediacentre/factsheets/fs211/en/.
26. WHO Sequencing Primers and Protocol 2009, Available from http://www.who.int/csr/resources/publications/swineflu/GenomePrimers_20090512.pdf.
27. WHO Influenza A Virus Resistance to Oseltamivir and other Antiviral Medicines 2010, Available from http://www.who.int/csr/disease/influenza/2008-9nhemisummaryreport/en/index.html Accessed 25 February 2010.
28. WHO Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010. Wkly. Epidemiol. Rec. 2010, 85:37-40.
29. Yang J.R., Lo J., Liu J.L., Lin C.H., Ho Y.L., Chen C.J., Wu H.S., Liu M.T. Rapid SYBR green I and modified probe real-time reverse transcription-PCR assays identify influenza H1N1 viruses and distinguish between pandemic and seasonal strains. J. Clin. Microbiol. 2009, 47:3714-3716.